Femtobiomed Cash Flow Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2018	FY 2017
Period Ending	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Net Income	-1,210	-1,070
Depreciation & Amortization	124.75	141.76
Loss (Gain) From Sale of Assets	-	-1.63
Provision & Write-off of Bad Debts	1.82	-
Other Operating Activities	14.02	18.74
Change in Accounts Receivable	47.56	-14.04
Change in Inventory	-83.05	18.89
Change in Accounts Payable	-	-0.92
Change in Other Net Operating Assets	6.38	-16.74
Operating Cash Flow	-1,099	-923.94
Capital Expenditures	-134.72	-72.21
Sale of Property, Plant & Equipment	-	31.74
Sale (Purchase) of Intangibles	-91.01	-10.23
Other Investing Activities	-4.91	-98.35
Investing Cash Flow	-230.64	-140.55
Long-Term Debt Repaid	-61.05	-66.6
Net Debt Issued (Repaid)	-61.05	-66.6
Financing Cash Flow	-61.05	-66.6
Net Cash Flow	-1,390	-1,131
Free Cash Flow	-1,233	-996.14
Free Cash Flow Margin	-316.28%	-251.83%
Free Cash Flow Per Share	-892.82	-721.51
Levered Free Cash Flow	-890.34	-
Unlevered Free Cash Flow	-889.89	-
Change in Working Capital	-29.1	-12.82

Source: S&P Global Market Intelligence. Standard template. Financial Sources.